文献速递胸部CT

基于整合影像组学列线图对非小细胞肺癌患者生存的预测与验证

Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
PubMed 文献 · Clin Radiol · 2021-12-31

研究纳入172例非小细胞肺癌患者构建列线图,另用74例内部验证和72例外部队列测试,从三维CT提取828个影像组学特征生成radscore并结合临床病理与常规CT参数。列线图在训练、内部验证和外部队列的c-index分别为0.670、0.658和0.660,校准曲线显示预测生存时间接近实际生存时间,低风险组1、2、5年生存率高于高风险组。

要点

  • 列线图整合radscore、临床病理因素和常规CT参数,可提高NSCLC生存预测准确性。
  • 训练、内部验证和外部队列的c-index分别为0.670、0.658和0.660。
  • 低风险组1、2、5年生存率均高于高风险组。

核心结论

  • 整合radscore、临床病理因素和常规CT参数的列线图可提高非小细胞肺癌患者生存预测的准确性。

研究设计与样本

  • 研究为列线图开发与验证研究,172例非小细胞肺癌患者用于构建模型,74例用于内部验证,72例用于外部测试。
  • 从每例患者的三维CT图像中提取828个影像组学特征,采用单因素Cox回归和LASSO回归筛选特征并生成影像组学标签(radscore)。
  • 通过校准曲线、临床实用性和c-index评价列线图性能,并用Kaplan-Meier分析比较两组的总生存期。

诊断标准与关键数值

  • 列线图在训练队列、内部验证队列和外部测试队列的c-index分别为0.670、0.658和0.660。
  • 校准曲线显示预测生存时间接近实际生存时间。
  • 决策曲线分析显示列线图在临床中可能有用。
  • Kaplan-Meier分析显示低风险组1、2、5年生存率高于高风险组。

临床应用与阅片要点

  • 原文结论认为列线图可提高非小细胞肺癌患者生存预测的准确性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To develop and validate a nomogram to predict 1-, 2-, and 5-year survival in patients with non-small-cell lung cancer (NSCLC) by combining optimised radiomics features, clinicopathological factors, and conventional image features extracted from three-dimensional (3D) computed tomography (CT) images.

MATERIALS AND METHODS: A total of 172 patients with NSCLC were selected to construct the model, and 74 and 72 patients were selected for internal validation and external testing, respectively. A total of 828 radiomics features were extracted from each patient's 3D CT images. Univariable Cox regression and least absolute shrinkage and selection operator (LASSO) regression were used to select features and generate a radiomics signature (radscore). The performance of the nomogram was evaluated by calibration curves, clinical practicability, and the c-index. Kaplan-Meier (KM) analysis was used to compare the overall survival (OS) between the two subgroups.

RESULT: The radiomics features of the NSCLC patients correlated significantly with survival time. The c-indexes of the nomogram in the training cohort, internal validation cohort, and external test cohort were 0.670, 0.658, and 0.660, respectively. The calibration curves showed that the predicted survival time was close to the actual survival time. Decision curve analysis shows that the nomogram could be useful in the clinic. According to KM analysis, the 1-, 2- and 5-year survival rates of the low-risk group were higher than those of the high-risk group.

CONCLUSION: The nomogram, combining the radscore, clinicopathological factors, and conventional CT parameters, can improve the accuracy of survival prediction in patients with NSCLC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Peng, Xue, et al. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram. Clin Radiol. 2021. PMID: 34974912. doi:10.1016/j.crad.2021.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。